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Abstract 
 
Short-chain fatty acids (SCFAs) are produced by bacterial fermentation in the large 
intestine, particularly from diets containing fibres and carbohydrates. The small 
intestinal epithelium is exposed toSCFAsderivedmainly fromoral bacteriaor food 
supplementation. Although luminal nutrients are important in regulation of intestinal 
functions, the role of SCFAs in regulation of small intestinal mucosal barrier function 
and motility has not been fully described. The aim of the present study was to elucidate 
the effects of acetate and propionate on duodenal mucosal barrier function and motility. 
Rats were anaesthetized with thiobarbiturate, and a 30 mm segment of proximal 
duodenum with an intact blood supply was perfused. The effects on duodenal 
bicarbonate secretion, blood-to-lumen clearance of 51Cr-EDTA, motility and 
transepithelial net fluid flux were investigated. Perfusion of the duodenum with acetate 
or propionate significantly decreased mucosal paracellular permeability and 
transepithelial net fluid flux and significantly increased bicarbonate secretion. Acetate or 
propionate administered as an i.v. infusion decreased the mucosal paracellular 
permeability, but significantly decreased bicarbonate secretion. Luminal SCFAs changed 
the duodenal motility pattern from migrating motor complexes to fed patterns. Systemic 
administration of glucagon-like peptide-2 induced increases in both bicarbonate 
secretion and net fluid absorption, but did not change motility. Glucagon-like peptide-2 
infusion during luminal perfusion of SCFAs significantly reduced the motility. In 
conclusion, SCFAs decreased duodenal paracellular permeability and net fluid flux. 
Short-chain fatty acids induced opposite effects on bicarbonate secretion after luminal 
and i.v. administration. Presence of SCFAs in the lumen induces fed motility patterns. 
Altered luminal chemosensing and aberrant signalling in response to SCFAs might 
contribute to symptoms observed in patients with suppressed barrier function. 
